Tobacco mosaic virus (TMV) RNA was encapsulated in large, unilamellar phospholipid vesicles (liposomes), and the encapsulated TMV RNA was shown to be infectious when incubated with tobacco protoplasts under appropriate conditions. Maximal virus production in protoplasts was observed after their incubation with TMV RNA entrapped in phosphatidylserine/ cholesterol liposomes. Infection was dependent on the presence of polyalcohols in the incubation mixture. Other parameters, such as the extent of vesicle binding, the cell-induced leakage of vesicle contents, and the degree of liposome toxicity were shown to be important in determining the efficiency of infectivity. Liposomemediated delivery offers an efficient and reproducible method for introducing RNA into plant protoplasts.
Because of their ability to fuse directly with the plasma membrane or to be taken up by cells by an endocytosis-like process, liposomes have been used to introduce a variety of molecules, including drugs and enzymes into cultured mammalian cells (1, 2) . Recent improvements in liposome technology (3, 4) now permit the encapsulation of large macromolecules such as nucleic acids in liposomes, and it has recently been shown that liposome-encapsulated RNA and DNA molecules can be introduced and expressed in a variety of mammalian cell lines (for review, see 5) .
Liposomes offer several advantages as carriers for delivering nucleic acids into cultured cells, including (i) protection of entrapped RNA and DNA molecules from degradation by nucleases, (ii) low toxicity towards cells, (iii) effective utilization with a variety of cell types, and (iv) enhanced efficiency of expression of the encapsulated nucleic acid. These advantages have been recognized by several laboratories (6) (7) (8) (9) (10) (11) (12) which have attempted to use liposomes to introduce nucleic acids into plant protoplasts. However, to date there have been no reports describing the expression of liposome-encapsulated nucleic acids by plant cells.
We have investigated liposome-protoplast interactions in order to optimize the delivery of liposomal contents to protoplasts and to determine the potential of this delivery system for introducing nucleic acids into plant cells. This study reports on optimal conditions for delivering liposome-encapsulated tobacco mosaic virus (TMV) RNA in a biologically-active form to tobacco protoplasts as a convenient assay for monitoring the delivery of nucleic acids into plant cells.
MATERIALS AND METHODS
TMV RNA Isolation and Encapsulation in Liposomes. RNA was extracted from virus (TMV strain U1) by the method ofDiazRuiz and Kaper (13) and stored in ethanol at -80°C until use. Liposomes were prepared by the method of Szoka and Papahadjopoulos (14) as modified by Fraley et al. (15) (17) , and RNA encapsulation was determined by monitoring an aliquot (25-50 ,ul) for radioactivity. Typically, between 30-40% of the TMV RNA was encapsulated by this procedure. The integrity of the encapsulated RNA was determined by extracting the RNA from liposomes by the method of Bligh and Dyer (except that isopropanol was substituted for methanol; ref. 18 ) and analyzing it by gel electrophoresis (19) .
Protoplast Isolation, Incubation, and Culture. Tobacco protoplasts were isolated from suspension cultures ofNicotiana tabacum "Xanthi" (n. c.) as described by Uchimiya and Murashige (20) and were resuspended at a final cell density of2 x 106 cells per ml in Tris-buffered mannitol solution (TBM solution; 5 mM Tris/0.5 M mannitol/0.5 mM CaCl2, pH 7.0). Liposomes (10-500 nmol of phospholipid) were added to 0.5 ml of protoplasts (in a 15.0-ml plastic centrifuge tube), mixed, and allowed to incubate for 5.0 min at 25°C. TBM (4.5 ml) containing 5% (vol/vol) glycerol, 5% (vol/vol) dimethyl-sulfoxide, 5% (vol! vol) ethylene glycol, 10% (wt/vol) polyvinyl alcohol (PVA) (Polysciences, no. 2975), or 10% (wt/vol) polyethylene glycol (PEG) (Mr = 6000; British Drug House, Poole, England) was added to the protoplast suspension and allowed to incubate for 20 min. The viscous solutions then were diluted by the addition of 10 ml ofTBM solution, and the protoplasts were pelleted by centrifugation (100 X g for 10 min The determination ofcell-associated vesicle lipid and vesicle contents was as described except that after liposome/cell incubation, the protoplasts were washed twice by centrifugation in TBM solution containing 2% Ficoll (the liposomes cannot enter solutions of this density, whereas the protoplasts pellet during centrifugation). The cells were resuspended in 1.0 ml of TBM solution and transferred directly to scintillation vials for determination of cell-associated radioactivity.
Radioimmunoassay for Monitoring TMV Production in Protoplasts. Rabbit anti-TMV antiserum was prepared as described (23) , and iodinations were performed with Enzymo Beads (BioRad) according to the manufacturer's directions. Microtiter plates (Dynatech Laboratories, Alexandria, VA) were precoated with unlabeled anti-TMV antibody (10 yg/ml in 50 mM phosphate buffer, pH 9.0) and washed three times with phosphatebuffered saline (containing 1% bovine serum albumin) before use. Aliquots of protoplasts (subjected twice to freeze/thaw cycle) or dilutions of TMV were added to wells and incubated for [12] [13] [14] [15] [16] [17] [18] hr at 250C; the wells were washed three times with phosphate-buffered saline (containing 1% bovine serum albumin), and 125 u1 of the Iff-labeled antibody (r200,000 cpm) was added and allowed to incubate for 3.0 hr. The wells were washed five times with phosphate-buffered saline, separated, and transferred to scintillation vials for the determination of radioactivity. The assay detects 1 ng of virus (at twice background levels); at saturating amounts of virus (> 1 pg), =3-5% of the labeled antibody was bound. The reproducibility of the results was quite good; all experimental points were determined in triplicate, and a variation of <14% was observed between separate samples. The values from independent experiments agreed within a factor of 2.
RESULTS
A variety of different liposome preparations, including neutral (6, 10), negative (8) (9) (10) (11) , and positively charged (7, 10, 12) vesicles, have been reported to have been successfully used to introduce encapsulated materials into plant protoplasts. TMV RNA was encapsulated in each of these different vesicle types to determine which liposome composition was optimal for delivery of TMV RNA into protoplasts (Table 1) . However, preliminary experiments in which tobacco protoplasts were simply incubated with these various liposome preparations resulted in no detectable virus production. The lack of infectivity of the liposome-encapsulated TMV RNA was not attributable to degradation because analysis of the encapsulated RNA on agarose gels revealed no breakdown had occurred during encapsulation (data not shown), and infection with the free RNA could be obtained by using the poly-L-ornithine method. Instead, a number of factors, including (i) inefficient binding of liposomes to protoplasts, (ii) leakage of encapsulated RNA from liposomes during incubation with cells, (iii) failure of liposomes to introduce their contents intracellularly, and (iv) possible toxic effects of liposomes on cells could account for the lack of infectivity of the encapsulated TMV RNA. These factors were examined to determine their possible influence on liposome-protoplast with 2 x 105 protoplasts, and the amounts of cell-associated vesicle lipid remaining after extensive washing of the protoplasts was determined (Fig. LA) . It should be emphasized that this experimental approach does not distinguish between liposomes adsorbed to the cell surface and those taken up by protoplasts by fusion, endocytosis, or some other process; therefore, these vesicles are referred to as cell-associated. Positively charged liposomes [PtdCho/stearyl amine (SteN) liposomes] were found to associate with protoplasts to a much greater degree than either neutral PtdCho or negatively charged [phosphatidylserine (PtdSer)] liposomes (Fig. LA) . The level of binding of the various liposome preparations (Fig. LA) was =10-to 100-fold greater than had been observed previously with mammalian cells (15, 24, 25) , suggesting that inefficient binding is not a likely cause for the lack of infectivity of encapsulated TMV RNA.
Because liposomes are known to exhibit increased permeability during their incubation with both mammalian cells (15) and plant protoplasts (6), it is important to measure the amount of vesicle contents that become cell-associated to determine if cell-induced leakage can account for the lack of infectivity. For this purpose, liposomes containing [3H]inulin (Fig. 1B) glycol after their incubation with liposomes (ref. 15 , unpublished data). Therefore, a variety of postincubation treatments were examined for their ability to stimulate liposome delivery and to increase the infectivity of encapsulated TMV RNA. Of the various treatments examined, exposure of tobacco protoplasts to dilute PVA solutions proved most effective in stimulating TMV RNA infectivity and was studied in detail ( Table 2 ). The PVA treatment was specific for PtdSer liposomes (Table 1) , and the relative infectivities of the various liposome preparations at different liposome concentrations is shown in Fig. 3 . The infectivity of PtdSer liposomes could be enhanced substantially (5-to 6-fold) by including an equimolar concentration of cholesterol (Chol) in the preparation (Table 1 and Fig. 3) . Chol had no effect on vesicle binding to protoplasts (Fig. 1A) but significantly increased the amount of vesicle contents that became cell-associated (Fig. 1B ) from 10.4% to 90%. Adding Chol to either neutral or positively charged liposome preparations had no effect on delivery (unpublished observations). (6) (7) (8) (9) (10) (11) , and cell fractionation and autoradiography have been used in attempts to localize the labeled nucleic acids within the cell. Although the results of these earlier stud- ies were encouraging, they also were ambiguous because the assays used could not distinguish between adsorption of liposomes to the cell surface and intracellular delivery (1, 2) . In addition, it has been demonstrated that damaged protoplasts (29) and isolated nuclei (30) may bind substantial amounts of nucleic acids. As a result, inference that the intracellular delivery of radioactive DNA sequestered in liposomes has occurred based strictly on the localization ofradioactivity in nuclei could give misleading results. The use of a biological assay for monitoring liposome-mediated delivery overcomes these uncertainties and allows for the unambiguous determination ofconditions that favor intracellular delivery.
Our results indicate that negatively charged (PtdSer/Chol) liposomes are the most efficient carrier for introducing TMV RNA into tobacco protoplasts. This observation is somewhat surprising because protoplasts are highly negatively charged (31) , but the superiority of PtdSer/Chol liposomes can at least be partially understood in terms of a combination of their high affinity for cells (Fig. 1A) , resistance to protoplast-induced leakage ofvesicle contents (Fig. 1B) , and their relatively low toxicity (compared with positively charged liposomes) to protoplasts (Fig. 2) . These observations are not limited to tobacco cells because similar results have been obtained for the delivery of liposome-encapsulated cowpea mosaic virus RNA to cowpea protoplasts (unpublished data).
The role of Chol in enhancing the infectivity ofliposome-encapsulated TMV RNA correlates with its ability to reduce the extent of vesicle leakiness during incubation with cells. Therefore, the net result is an increased amount ofencapsulated TMV RNA that remains available for intracellular delivery. Similar effects of Chol in enhancing simian virus 40 DNA delivery to mammalian cells have been observed (15) . These results are in conflict with those of Ostro et al. (8) , which indicate that the inclusion of Chol in negatively-charged liposomes actually decreases the extent of liposomal delivery. It should be emphasized, though, that the latter study utilized an assay based on the uptake of radioactively labeled DNA.
The absolute efficiency of virus production after liposomemediated delivery of TMV RNA to protoplasts (-400-500 ng of virus per 105 protoplasts; Table 3 ) is comparable or greater than values reported for TMV RNA infection mediated by polycations (Table 2 ; ref. 28) or alkaline pH (32); however, absolute comparisons are difficult to make because of the different cell preparations used in these studies (suspension cells vs. leaf tissue). Under optimal conditions, =20% of the tobacco protoplasts become stained with fluorescein-labeled anti-TMV antibody (33) 48 hr after incubation with liposome-encapsulated TMV RNA. Other important advantages of liposome-mediated delivery are its high degree of reproducibility and the fact that once the RNA is encapsulated in liposomes, it remains stable for several weeks and may be used for many experiments. Finally, although minor changes in incubation conditions are required for maximal liposome delivery in other protoplast systems (cowpea, petunia, tobacco mesophyll, etc.), this method appears to be generally applicable to use with all plant species.
The mechanism by which the PVA and PEG treatments stimulate intracellular delivery ofliposomal contents is not yet clear. These agents are known to induce protoplast-protoplast fusion (27, 34) and also may be able to facilitate liposome-protoplast fusion as well. Alternatively, PEG and PVA may stimulate liposome uptake by an endocytosis-like process, as has been suggested for the action ofglycerol in enhancing liposome delivery with mammalian cells (15, 35) . Although such processes have not been clearly elucidated in plant cells, there have been several reports describing the uptake of large particles by protoplasts (34, 36) , particularly after treatment with PEG. Our ef-forts are directed towards understanding these aspects of liposome-protoplast interaction and increasing further the efficiency of liposome-mediated delivery to plant cells.
